ARTV vs GOEV
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus GOEV (GOEV) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
GOEV (GOEV) common stock.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
GOEV does not have a complete income-statement cache yet.
ARTV currently screens at market cap $37.3M.
Not investment advice. Open the ARTV and GOEV stock pages for the full models.
Not investment advice.